Get the Stockscreener App
34.03
1.02%
-0.35
Pre-market:
34.20
0.17
+0.50%
Procept Biorobotics Corp stock is traded at $34.03, with a volume of 1.02M.
It is down -1.02% in the last 24 hours and down -4.65% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$34.38
Open:
$34.88
24h Volume:
1.02M
Relative Volume:
0.89
Market Cap:
$1.89B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-20.02
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-2.74%
1M Performance:
-4.65%
6M Performance:
-36.96%
1Y Performance:
-62.19%
1-Day Range:
$33.68
$34.88
1-Week Range:
$33.68
$37.28
52-Week Range:
$32.11
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
34.03 | 1.91B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Bessemer Group Inc. Acquires 7,435 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
What hedge fund activity signals for PROCEPT BioRobotics Corporation stockM&A Rumor & Verified Swing Trading Watchlists - newser.com
Procept Biorobotics Corp expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Procept Biorobotics’ WATER IV Study: A Game Changer in Prostate Cancer Treatment? - MSN
How institutional ownership impacts PROCEPT BioRobotics Corporation stock2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
How to track smart money flows in PROCEPT BioRobotics CorporationBuy Signal & Weekly Stock Performance Updates - newser.com
Live market analysis of PROCEPT BioRobotics Corporation2025 Momentum Check & Smart Swing Trading Techniques - newser.com
PROCEPT BioRobotics Corporation (PRCT) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Oppenheimer Upgrades PROCEPT BioRobotics (PRCT) - MSN
Earnings Preview: PROCEPT BioRobotics Corporation (PRCT) Q3 Earnings Expected to Decline - Yahoo Finance
PROCEPT BioRobotics (PRCT) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Procept Biorobotics’ Aquablation Therapy Study: A Potential Game-Changer for Prostate Treatment - TipRanks
Will PROCEPT BioRobotics Corporation stock outperform tech sector in 2025Market Rally & Weekly Stock Performance Updates - newser.com
Can volume confirm reversal in PROCEPT BioRobotics CorporationMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Using data filters to optimize entry into PROCEPT BioRobotics Corporation2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
How to integrate PROCEPT BioRobotics Corporation into portfolio analysis tools - newser.com
PRCT.MX interactive stock chart | PROCEPT BIOROBOTICS CORP stock - Yahoo! Finance Singapore
Applying chart zones and confluence areas to PROCEPT BioRobotics CorporationEarnings Risk Summary & Low Drawdown Trading Strategies - newser.com
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? - sharewise.com
Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating - Insider Monkey
What drives PROCEPT BioRobotics Corporation stock priceSector Rotation Strategies & Our Experts Decode Market Noise for You - earlytimes.in
Will PROCEPT BioRobotics Corporation stock benefit from automationJuly 2025 Trade Ideas & Precise Buy Zone Tips - Trung tâm Dự báo KTTV quốc gia
Why PROCEPT BioRobotics Corporation stock attracts high net worth investorsWeekly Loss Report & Accurate Buy Signal Notifications - Trung tâm Dự báo KTTV quốc gia
Is PROCEPT BioRobotics Corporation stock attractive for long term wealth buildingEarnings Performance Report & Consistent Profit Focused Trading Strategies - Trung tâm Dự báo KTTV quốc gia
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
14.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):